Table 3.
Overall (N = 90) | Levetiracetam (n = 18) | Phenytoin (n = 72) | P value | |
EEG findings | 26 (29) | 5 (28) | 21 (29) | .99 |
Generalized convulsive status epilepticus | 2 (8) | 0 (0) | 2 (10) | .99 |
Nonconvulsive status epilepticus | 13 (50) | 2 (40) | 11 (52) | .99 |
Periodic epileptiform discharges | 17 (65) | 2 (40) | 15 (71) | .30 |
Seizure not otherwise specified | 3 (12) | 2 (40) | 1 (5) | .08 |
Clinical seizure activity | 13 (14.4) | 2 (11) | 11 (15.3) | .79 |
Time to seizure activity, days (IQR) | 5 (4-10) | 4 (3-11) | 6 (4-19) | .24 |
Continuous EEG monitoring | 48 (53.3) | 8 (44.4) | 40 (55.6) | .40 |
Note: Values are given as n (%), unless otherwise indicated.